Infectious colitis

Current Opinion in Gastroenterology

Volumn 27, Issue 1, 2011, Pages 66-71

  Navaneethan, Udayakumar ^a   Giannella, Ralph A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Campylobacter; Escherichia coli; Infectious colitis; Irritable bowel syndrome; Salmonella

Indexed keywords

ANTIBIOTIC AGENT; LIGASE; STAT1 PROTEIN;

AMEBIASIS; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAMPYLOBACTER ENTERITIS; COHORT ANALYSIS; COLITIS; CONFIDENCE INTERVAL; DEPHOSPHORYLATION; ENZYME ACTIVITY; ESCHERICHIA COLI INFECTION; GENETIC CODE; HAZARD RATIO; HUMAN; HYBRIDIZATION; IRRITABLE COLON; NONHUMAN; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLOSIS; SHIGELLOSIS;

CAMPYLOBACTER INFECTIONS; COLITIS; ESCHERICHIA COLI INFECTIONS; HUMANS; IRRITABLE BOWEL SYNDROME; SALMONELLA INFECTIONS;

EID: 79951678326     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283400755     Document Type: Article

References (49)

1. Kosek M, Bern C, Guerrant RL. The global burden of diarrheal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003; 81:197-204. (Pubitemid 36372958)
2. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part II: Lower gastrointestinal diseases. Gastroenterology 2009; 136:741-754.
3. Navaneethan U, Giannella RA. Mechanisms of infectious diarrhea. Nat Clin Pract Gastroenterol Hepatol 2008; 5:637-647.
4. Vugia D, Cronquist A, Hadler J, et al. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 states, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:366-370.
5. Maki DG. Coming to grips with foodborne infection: Peanut butter, peppers, and nationwide salmonella outbreaks. N Engl J Med 2009; 360:949-953. This report discusses the role of nonpoultry sources of Salmonella infection.
6. Franz E, van Bruggen AH. Ecology of E. coli O157:H7 and Salmonella enterica in the primary vegetable production chain. Crit Rev Microbiol 2008; 34:143-161.
7. Carnell SC, Bowen AJ, Morgan E, et al. Role in virulence and protective efficacy in pigs of Salmonella enterica serovar Typhimurium secreted components identified by signature tagged mutagenesis. Microbiology 2007; 153:1940-1952. (Pubitemid 46952524)
8. Morgan E, Chaudhuri RR, Peters SE, et al. Comprehensive genome-wide survey of Salmonella enterica serovar Typhimurium colonisation factors of cattle, pigs and chickes by transposon-mediated differential hybridisation, abstr. S4:5. Salmonella: Biology, pathogenesis and prevention. Washington, DC: American Society for Microbiology; 2009.
9. Chen J, Zhang L, Paoli GC, et al. A real-time PCR method for the detection of Salmonella enterica from food using a target sequence identified by comparative genomic analysis. Int J Food Microbiol 2010; 137:168-174.
10. Hapfelmeier S, Stecher B, Barthel M, et al. The Salmonella pathogenicity island (SPI)-2 and SPI-1 type III secretion systems allow Salmonella serovar Typhimurium to trigger colitis via MyD88-dependent and MyD88-independent mechanisms. J Immunol 2005; 174:1675-1685.
11. Murray RA, Lee CA. Invasion genes are not required for Salmonella enterica serovar Typhimurium to breach the intestinal epithelium: Evidence that Salmonella pathogenicity island 1 has alternative functions during infection. Infect Immun 2000; 68:5050-5055.
12. Gradel KO, Nielsen HL, Schønheyder HC, et al. Increased short- and long term risk of inflammatory bowel disease after Salmonella or Campylobacter gastroenteritis. Gastroenterology 2009; 137:495-501. A registry-based study from Denmark demonstrated that the risk of developing both Crohn's disease and ulcerative colitis is increased in previously well patients with an acute bacterial enteric infection.
13. Finlay B. New insights into Salmonella interactions with the host and microbiota, abstr. S5:5. Salmonella: Biology, pathogenesis and prevention. Washington, DC: American Society for Microbiology; 2009.
14. Grassl GA, Valdez Y, Bergstrom YS, et al. Chronic enteric Salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology 2008; 134:768-780.
15. Giannella RA. Infectious enteritis and proctocolitis and food poisoning. In: Feldman M, Friedman LS, Brandt LJ, editors, Sleisenger & Fordtran's gastrointestinal and liver disease. 8th ed. Saunders: Elsevier; 2006. p. 104.
16. Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food: Appreciate 10 states, 2009. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep 2010; 59:418-422.
17. Phalipon A, Sansonetti PJ. Shigellosis: Innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development. Crit Rev Immunol 2003; 23:371-401. (Pubitemid 38222907)
18. Arbibe L, Kim DW, Batsche E, et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol 2007; 8:47-56. (Pubitemid 46242358)
19. Ashida H, Kim M, Schmidt-Supprian M, et al. A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response. Nat Cell Biol 2010; 12:66-73.
20. Papayannopoulos V, Zychlinsky A. NETs: A new strategy for using old weapons. Trends Immunol 2009; 30:513-521.
21. Sperandio B, Regnault B, Guo J, et al. Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression. J Exp Med 2008; 205:1121-1132. (Pubitemid 351679687)
22. Prince Christopher RH, David KV, John SM, Sankarapandian V. Antibiotic therapy for Shigella dysentery. Cochrane Database Syst Rev 2010: CD006784.
23. Ternhag A, Torner A, Svensson A, et al. Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis 2008; 14:143-148.
24. Van Putten JP, van Alphen LB, Wö sten MM, de Zoete MR. Molecular mechanisms of campylobacter infection. Curr Top Microbiol Immunol 2009; 337:197-229.
25. Hu L, Tall BD, Curtis SK, Kopecko DJ. Enhanced microscopic definition of Campylobacter jejuni 81-176 adherence to, invasion of, translocation across, and exocytosis from polarized human intestinal Caco-2 cells. Infect Immun 2008; 76:5294-5304.
26. Dasti JI, Tareen AM, Lugert R, et al. Campylobacter jejuni: A brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol 2010; 300:205-211.
27. Watson RO, Galan JE. Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathog 2008; 4:e14.
28. Friis LM, Keelan M, Taylor DE. Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2. Infect Immun 2009; 77:1553-1560.
29. Rathinam VAK, Appledorn DM, Hoag KA, et al. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes. Infect Immun 2009; 77:2499-2507.
30. Wine E, Chan VL, Sherman PM. Campylobacter jejuni mediated disruption of polarized epithelial monolayers is cell-type specific, time dependent, and correlates with bacterial invasion. Pediatr Res 2008; 64:599-604.
31. Marshall JK, Thabane M, Garg AX, et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 2010; 59:605-611. This 8-year follow-up study from Walkerton, Canada demonstrated that the risk of developing post infectious irritable bowel syndrome is increased in patients with an acute bacterial enteric infection with EHEC and Campylobacter jejuni.
32. Lim JY, Yoon J, Hovde CJ. A brief overview of Escherichia coli O157:H7 and its plasmid O157. J Microbiol Biotechnol 2010; 20:5-14.
33. Mellmann A, Bielaszewska M, Karch H. Intrahost genome alterations in enterohemorrhagic Escherichia coli. Gastroenterology 2009; 136:1925-1938.
34. Vingadassalom D, Kazlauskas A, Skehan B, et al. Insulin receptor tyrosine kinase substrate links the E. coli O157:H7 actin assembly effectors Tir and EspF(U) during pedestal formation. Proc Natl Acad Sci U S A 2009; 106: 6754-6759.
35. Pawlowski SW, Warren CA, Guerrant R. Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology 2009; 136:1874-1886.
36. Bhavsar AP, Guttman JA, Finlay BB. Manipulation of host-cell pathways by bacterial pathogens. Nature 2007; 449:827-834. (Pubitemid 47598623)
37. Jandu N, Zeng ZJ, Johnson-Henry KC, Sherman PM. Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon- g-induced tyrosine phosphorylation of STAT-1. Microbiology 2009; 155:531-540.
38. Johnson-Henry KC, Donato KA, Shen-Tu G, et al. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun 2008; 76:1340-1348. (Pubitemid 351561979)
39. Reissbrodt R, Hammes WP, dal Bello F, et al. Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol Lett 2009; 290:62-69.
40. Huston CD. Parasite and host contributions to the pathogenesis of amebic colitis. Trends Parasitol 2004; 20:23-26. (Pubitemid 38045235)
41. Ximénez C, Cerritos R, Rojas L, et al. Human amebiasis: Breaking the paradigm? Int J Environ Res Public Health 2010; 7:1105-1120. This study reports E. dispar as being pathogenic in causing amebiasis.
42. Ali IK, Mondal U, Roy S, et al. Evidence for a link between parasite genotype and outcome of infection with Entamoeba histolytica. J Clin Microbiol 2007; 45:285-289.
43. Ali IK, Solaymani-Mohammadi S, Akhter J, et al. Tissue invasion by Entamoeba histolytica: Evidence of genetic selection and/or DNA reorganization events in organ tropism. PLoS Neglect Trop Dis 2008; 2:e219.
44. Lorenzi HA, Puiu D, Miller JR, et al. New assembly, reannotation and analysis of the Entamoeba histolytica genome reveal new genomic features and protein content information. PLoS Negl Trop Dis 2010; 4:e716.
45. Duggal P, Haque R, Roy S, et al. Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children. J Infect Dis 2004; 189:520-526. (Pubitemid 38213163)
46. Moncada D, Keller K, Chadee K. Entamoeba histolytica cysteine proteinases disrupt the polymeric structure of colonic mucin and alter its protective function. Infect Immun 2003; 71:838-844. (Pubitemid 36150778)
47. Padilla-Vaca F, Anaya-Velázquez F. Insights into Entamoeba histolytica virulence modulation. Infect Disord Drug Targets 2010; 10:242-250.
48. Cho KN, Becker SM, Houpt ER. The NF-kappaB p50 subunit is protective during intestinal Entamoeba histolytica infection of 129 and C57BL/6 mice. Infect Immun 2010; 78:1475-1481.
49. Carrero JC, Contreras-Rojas A, Sánchez-Hernández B, et al. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin. Exp Parasitol 2010; 126:359-365.